Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease-Reference-Cited by-同舟云学术

Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease

Published:2015-02-06 Issue:2 Volume:10 Page:e0116841
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Shahaduzzaman Md,Nash Kevin,Hudson Charles,Sharif Masroor,Grimmig Bethany,Lin Xiaoyang,Bai Ge,Liu Hui,Ugen Kenneth E.,Cao Chuanhai,Bickford Paula C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. Quantitative analysis of alpha-synuclein solubility in living cells using split GFP complementation;A Kothawala;PLoS One,2012

2. Immunotherapy targeting alpha-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders;V Lindstrom;Immunotherapy,2014

3. Monoclonal antibodies selective for alpha-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and alpha-synuclein transgenic mice with the disease-causing A30P mutation;T Fagerqvist;J Neurochem,2013

4. Mandler M, Valera E, Rockenstein E, Weninger H, Patrick C, et al. (2014) Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials. Acta Neuropathol.

5. Alzheimer's disease and immunotherapy;J Madeo;Aging Dis,2013

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on immunotherapy in neurodegenerative diseases;Brain Research;2024-12

2. The humoral immune landscape in Parkinson's disease: Unraveling antibody and B cell changes;Cell Biochemistry and Function;2024-08-27

3. Non-transgenic models of Parkinson's disease: The pursuit of a resemblance;Brain Disorders;2024-06

4. Targeted Therapy for Neurological Disorders Using Nanomaterial-Based Drug Delivery Vehicle;Smart Nanomaterials Technology;2024

5. Production and characterization of a chimeric protein targeting synuclein epitopes for immunotherapy against synucleinopathies;Biotechnology Progress;2023-09-13